CDR-Life

CDR-Life develops T‑cell engagers to target solid tumor proteins. Lead pre-clinical programs focus on lung, bladder, and esophagus cancers.
Domain
Healthcare
Status
IPO’d/​Acquired
Stage of Initial Investment
Series A
Initial Investment Year
2022